Intent Solutions, the Atlanta, Georgia-based creator of the medication dispenser, closed $1.5m in seed funding.
The company intends to use the funds for ongoing technology and software development, additional patent filings, and sales and marketing.
Led by Sam Zamarripa, president, Intent Solutions provides TAD™ is a smart, mobile, medication dispenser that enables patients to take the right dose at the right time.
The medical device, which can be programmed to a specific regimen and schedule, incorporates biometric access and is fully tamper resistant. It also records adherence data, which is sent to a cloud database for analysis, reducing errors and simplifying data reconciliation for clinical trials.
TAD was conceived by Dr. Van Crisco, chairman, and Marty McClean, a director of the company.